New insights into retroviral Gag-Gag and Gag-membrane interactions

Frontiers in Microbiology

Volumn 5, Issue JUN, 2014, Pages

  Maldonado, José O ^a,b   Martin, Jessica L ^a,b   Mueller, Joachim D ^a,c   Zhang, Wei ^a,b   Mansky, Louis M ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota   (United States)

Author keywords

Deltaretrovirus; Lentivirus; Multimerization; Oligomerization; Plasma membrane; Spectroscopy

Indexed keywords

GAG PROTEIN; MEMBRANE LIPID; PHOSPHOLIPID; POLYPROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

CELL MEMBRANE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; INTRACELLULAR TRANSPORT; LIPID RAFT; MICROTUBULE; MOLECULAR INTERACTION; MYRISTYLATION; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; RETROVIRUS; SHORT SURVEY; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 84904887065     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00302     Document Type: Short Survey

References (77)

1. Accola, M. A., Strack, B., and Gottlinger, H. G. (2000). Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 74, 5395-5402. doi: 10.1128/JVI.74.12.5395-5402.2000
2. Ako-Adjei, D., Johnson, M. C., and Vogt, V. M. (2005). The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles. J. Virol. 79, 13463-13472. doi: 10.1128/JVI.79.21.13463-13472.2005
3. Alfadhli, A., Dhenub, T. C., Still, A., and Barklis, E. (2005). Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly. J. Virol. 79, 14498-14506. doi: 10.1128/JVI.79.23.14498-14506.2005
4. Bello, N. F., Dussupt, V., Sette, P., Rudd, V., Nagashima, K., Bibollet-Ruche, F.,et al. (2012). Budding of retroviruses utilizing divergent L domains requires nucleocapsid. J. Virol. 86, 4182-4193. doi: 10.1128/JVI.07105-11
5. Borsetti, A., Ohagen, A., and Gottlinger, H. G. (1998). The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72, 9313-9317.
6. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J.,et al. (2008). Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926. doi: 10.1126/science.1152725
7. Briggs, J. A., and Krausslich, H. G. (2011). The molecular architecture of HIV. J. Mol. Biol. 410, 491-500. doi: 10.1016/j.jmb.2011.04.021
8. Briggs, J. A., Simon, M. N., Gross, I., Krausslich, H. G., Fuller, S. D., Vogt, V. M.,et al. (2004). The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11, 672-675. doi: 10.1038/nsmb785
9. Bryant, M., and Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 87, 523-527. doi: 10.1073/pnas.87.2.523
10. Chan, J., Dick, R. A., and Vogt, V. M. (2011). Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro. J. Virol. 85, 10851-10860. doi: 10.1128/JVI.00760-11
11. Chen, Y., Wu, B., Musier-Forsyth, K., Mansky, L. M., and Mueller, J. D. (2009). Fluorescence fluctuation spectroscopy on viral-like particles reveals variable gag stoichiometry. Biophys. J. 96, 1961-1969. doi: 10.1016/j.bpj.2008.10.067
12. Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W. S., and Ono, A. (2008). Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 82, 2405-2417. doi: 10.1128/JVI.01614-07
13. Chukkapalli, V., and Ono, A. (2011). Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J. Mol. Biol. 410, 512-524. doi: 10.1016/j.jmb.2011.04.015
14. Cimarelli, A., Sandin, S., Hoglund, S., and Luban, J. (2000). Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74, 3046-3057. doi: 10.1128/JVI.74.7.3046-3057.2000
15. Dalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D., and Vogt, V. M. (2007). Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81, 6434-6445. doi: 10.1128/JVI.02757-06
16. Datta, S. A., Heinrich, F., Raghunandan, S., Krueger, S., Curtis, J. E., Rein, A.,et al. (2011). HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J. Mol. Biol. 406, 205-214. doi: 10.1016/j.jmb.2010.11.051
17. Datta, S. A., Zhao, Z., Clark, P. K., Tarasov, S., Alexandratos, J. N., Campbell, S. J.,et al. (2007). Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365, 799-811. doi: 10.1016/j.jmb.2006.10.072
18. Dick, R. A., Goh, S. L., Feigenson, G. W., and Vogt, V. M. (2012). HIV-1 Gag protein can sense the cholesterol and acyl chain environment in model membranes. Proc. Natl. Acad. Sci. U.S.A. 109, 18761-18766. doi: 10.1073/pnas.1209408109
19. Dorfman, T., Bukovsky, A., Ohagen, A., Hoglund, S., and Gottlinger, H. G. (1994). Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68, 8180-8187.
20. Dussupt, V., Sette, P., Bello, N. F., Javid, M. P., Nagashima, K., and Bouamr, F. (2011). Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. J. Virol. 85, 2304-2315. doi: 10.1128/JVI.01562-10
21. Finzi, A., Orthwein, A., Mercier, J., and Cohen, E. A. (2007). Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81, 7476-7490. doi: 10.1128/JVI.00308-07
22. Finzi, A., Perlman, M., Bourgeois-Daigneault, M. C., Thibodeau, J., and Cohen, E. A. (2013). Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane. Cell. Microbiol. 15, 809-822. doi: 10.1111/cmi.12074
23. Fogarty, K. H., Berk, S., Grigsby, I. F., Chen, Y., Mansky, L. M., and Mueller, J. D. (2013). Interrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association. J. Mol. Biol. 426, 1611-1624. doi: 10.1016/j.jmb.2013.11.025
24. Fogarty, K. H., Chen, Y., Grigsby, I. F., Macdonald, P. J., Smith, E. M., Johnson, J. L.,et al. (2011). Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopy. Biophys. J. 100, 1587-1595. doi: 10.1016/j.bpj.2011.02.008
25. Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake, D. K., Wang, H.,et al. (1997). Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278, 849-853. doi: 10.1126/science.278.5339.849
26. Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T., and Sundquist, W. I.(1999). Assembly and analysis of conical models for the HIV-1 core. Science 283, 80-83. doi: 10.1126/science.283.5398.80
27. Gorelick, R. J., Henderson, L. E., Hanser, J. P., and Rein, A. (1988). Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc. Natl. Acad. Sci. U.S.A. 85, 8420-8424. doi: 10.1073/pnas.85.22.8420
28. Gousset, K., Ablan, S. D., Coren, L. V., Ono, A., Soheilian, F., Nagashima, K.,et al. (2008). Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 4:e1000015. doi: 10.1371/journal.ppat.1000015
29. Hamard-Peron, E., Juillard, F., Saad, J. S., Roy, C., Roingeard, P., Summers, M. F.,et al. (2010). Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix. J. Virol. 84, 503-515. doi: 10.1128/JVI.01134-09
30. Henderson, L. E., Bowers, M. A., Sowder, R. C. II, Serabyn, S. A., Johnson, D. G., Bess, J. W.,et al. (1992). Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66, 1856-1865.
31. Hirokawa, N., and Noda, Y. (2008). Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics. Physiol. Rev. 88, 1089-1118. doi: 10.1152/physrev.00023.2007
32. Hogue, I. B., Hoppe, A., and Ono, A. (2009). Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding. J. Virol. 83, 7322-7336. doi: 10.1128/JVI.02545-08
33. Inlora, J., Chukkapalli, V., Derse, D., and Ono, A. (2011). Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J. Virol. 85, 3802-3810. doi: 10.1128/JVI.02383-10
34. Jouvenet, N., Neil, S. J., Bess, C., Johnson, M. C., Virgen, C. A., Simon, S. M.,et al. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4:e435. doi: 10.1371/journal.pbio.0040435
35. Jouvenet, N., Simon, S. M., and Bieniasz, P. D. (2009). Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc. Natl. Acad. Sci. U.S.A. 106, 19114-19119. doi: 10.1073/pnas.0907364106
36. Khorchid, A., Halwani, R., Wainberg, M. A., and Kleiman, L. (2002). Role of RNA in facilitating Gag/Gag-Pol interaction. J. Virol. 76, 4131-4137. doi: 10.1128/JVI.76.8.4131-4137.2002
37. Konig, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M., Irelan, J. T.,et al. (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60. doi: 10.1016/j.cell.2008.07.032
38. Krausslich, H. G., Facke, M., Heuser, A. M., Konvalinka, J., and Zentgraf, H. (1995). The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69, 3407-3419.
39. Kutluay, S. B., and Bieniasz, P. D. (2010). Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog. 6:e1001200. doi: 10.1371/journal.ppat.1001200
40. Li, H., Dou, J., Ding, L., and Spearman, P. (2007). Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells. J. Virol. 81, 12899-12910. doi: 10.1128/JVI.01280-07
41. Lindwasser, O. W., and Resh, M. D. (2001). Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75, 7913-7924. doi: 10.1128/JVI.75.17.7913-7924.2001
42. Lingwood, D., Kaiser, H. J., Levental, I., and Simons, K. (2009). Lipid rafts as functional heterogeneity in cell membranes. Biochem. Soc. Trans. 37, 955-960. doi: 10.1042/BST0370955
43. Muriaux, D., Costes, S., Nagashima, K., Mirro, J., Cho, E., Lockett, S.,et al. (2004). Role of murine leukemia virus nucleocapsid protein in virus assembly. J. Virol. 78, 12378-12385. doi: 10.1128/JVI.78.22.12378-12385.2004
44. Murray, P. S., Li, Z., Wang, J., Tang, C. L., Honig, B., and Murray, D. (2005). Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13, 1521-1531. doi: 10.1016/j.str.2005.07.010
45. Nadaraia-Hoke, S., Bann, D. V., Lochmann, T. L., Gudleski-O'regan, N., and Parent, L. J. (2013). Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein. J. Virol. 87, 3609-3615. doi: 10.1128/JVI.03059-12
46. Naghavi, M. H., and Goff, S. P. (2007). Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 19, 402-407. doi: 10.1016/j.coi.2007.07.003
47. Nguyen, D. G., and Hildreth, J. E. (2003). Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483-493. doi: 10.1002/immu.200310024
48. Nishi, M., Ryo, A., Tsurutani, N., Ohba, K., Sawasaki, T., Morishita, R.,et al. (2009). Requirement for microtubule integrity in the SOCS1-mediated intracellular dynamics of HIV-1 Gag. FEBS Lett. 583, 1243-1250. doi: 10.1016/j.febslet.2009.03.041
49. Nydegger, S., Foti, M., Derdowski, A., Spearman, P., and Thali, M. (2003). HIV-1 egress is gated through late endosomal membranes. Traffic 4, 902-910. doi: 10.1046/j.1600-0854.2003.00145.x
50. O'Carroll, I. P., Crist, R. M., Mirro, J., Harvin, D., Soheilian, F., Kamata, A.,et al. (2012). Functional redundancy in HIV-1 viral particle assembly. J. Virol. 86, 12991-12996. doi: 10.1128/JVI.06287-11
51. O'Carroll, I. P., Soheilian, F., Kamata, A., Nagashima, K., and Rein, A. (2013). Elements in HIV-1 Gag contributing to virus particle assembly. Virus Res. 171, 341-345. doi: 10.1016/j.virusres.2012.10.016
52. Ono, A. (2009). HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4, 241-257. doi: 10.2217/fvl.09.4
53. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., and Freed, E. O. (2004). Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 101, 14889-14894. doi: 10.1073/pnas.0405596101
54. Ono, A., Orenstein, J. M., and Freed, E. O. (2000). Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74, 2855-2866. doi: 10.1128/JVI.74.6.2855-2866.2000
55. Ootsuyama, Y., Shimotohno, K., Miwa, M., Oroszlan, S., and Sugimura, T. (1985). Myristylation of gag protein in human T-cell leukemia virus type-I and type-II. Jpn. J. Cancer Res. 76, 1132-1135.
56. Oroszlan, S., and Copeland, T. D. (1985). Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. Curr. Top. Microbiol. Immunol. 115, 221-233. doi: 10.1007/978-3-642-70113-9_14
57. Pelchen-Matthews, A., Kramer, B., and Marsh, M. (2003). Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-455. doi: 10.1083/jcb.200304008
58. Perez-Caballero, D., Hatziioannou, T., Martin-Serrano, J., and Bieniasz, P. D. (2004). Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J. Virol. 78, 9560-9563. doi: 10.1128/JVI.78.17.9560-9563.2004
59. Purohit, P., Dupont, S., Stevenson, M., and Green, M. R. (2001). Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA 7, 576-584. doi: 10.1017/S1355838201002023
60. Qualley, D. F., Stewart-Maynard, K. M., Wang, F., Mitra, M., Gorelick, R. J., Rouzina, I.,et al. (2010). C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism. J. Biol. Chem. 285, 295-307. doi: 10.1074/jbc.M109.051334
61. Raposo, G., Moore, M., Innes, D., Leijendekker, R., Leigh-Brown, A., Benaroch, P.,et al. (2002). Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718-729. doi: 10.1034/j.1600-0854.2002.31004.x
62. Rayne, F., Bouamr, F., Lalanne, J., and Mamoun, R. Z. (2001). The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation. J. Virol. 75, 5277-5287. doi: 10.1128/JVI.75.11.5277-5287.2001
63. Rein, A., Datta, S. A., Jones, C. P., and Musier-Forsyth, K. (2011). Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem. Sci. 36, 373-380. doi: 10.1016/j.tibs.2011.04.001
64. Resh, M. D. (1999). Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451, 1-16. doi: 10.1016/S0167-4889(99)00075-0
65. Resh, M. D. (2004). A myristoyl switch regulates membrane binding of HIV-1 Gag. Proc. Natl. Acad. Sci. U.S.A. 101, 417-418. doi: 10.1073/pnas.0308043101
66. Sonnino, S., and Prinetti, A. (2013). Membrane domains and the "lipid raft" concept. Curr. Med. Chem. 20, 4-21. doi: 10.2174/0929867311320010003
67. Stansell, E., Apkarian, R., Haubova, S., Diehl, W. E., Tytler, E. M., and Hunter, E. (2007). Basic residues in the Mason-Pfizer monkey virus gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 81, 8977-8988. doi: 10.1128/JVI.00657-07
68. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D., and Summers, M. F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U.S.A. 101, 517-522. doi: 10.1073/pnas.0305665101
69. Vale, R. D. (2003). The molecular motor toolbox for intracellular transport. Cell 112, 467-480. doi: 10.1016/S0092-8674(03)00111-9
70. van Meer, G., Voelker, D. R., and Feigenson, G. W. (2008). Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124. doi: 10.1038/nrm2330
71. Vogt, V. M., and Simon, M. N. (1999). Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy. J. Virol. 73, 7050-7055.
72. von Schwedler, U. K., Stray, K. M., Garrus, J. E., and Sundquist, W. I. (2003). Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 77, 5439-5450. doi: 10.1128/JVI.77.9.5439-5450.2003
73. Welsch, S., Muller, B., and Krausslich, H. G. (2007). More than one door-budding of enveloped viruses through cellular membranes. FEBS Lett. 581, 2089-2097. doi: 10.1016/j.febslet.2007.03.060
74. Yeager, M., Wilson-Kubalek, E. M., Weiner, S. G., Brown, P. O., and Rein, A. (1998). Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc. Natl. Acad. Sci. U.S.A. 95, 7299-7304. doi: 10.1073/pnas.95.13.7299
75. Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C.,et al. (2008). Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504. doi: 10.1016/j.chom.2008.10.004
76. Zhou, W., Parent, L. J., Wills, J. W., and Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569.
77. Zhou, W., and Resh, M. D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70, 8540-8548.